Turnover: 42.997 billion USD (2022)
Country: France
A French pharmaceutical company of international stature
News
Sanofi plans to spin off its Consumer Healthcare business in 2024 28/10/2023
- Year of separate listing of Sanofi's Consumer Healthcare Division: 2024
- Sanofi envisages savings of: up to 2 billion euros between 2024 and the end of 2025
- Presence of Sanofi Consumer Healthcare Division: 150 countries, more than 11,000 employees
Sanofi to spin off its consumer healthcare division and float it on the stock market 27/10/2023
- Sanofi is a French pharmaceutical company
- The Consumer Healthcare division has over 11,000 employees in 150 countries.
- The demerger of Consumer Healthcare will take place in the fourth quarter of 2024 at the earliest.
- This division accounts for just over 10% of Group sales.
- In 2022, the Consumer Healthcare division generated 5.1 billion euros of Sanofi's 43 billion euros in sales.
- The Consumer Healthcare division posted growth of 13.7% in 2022.
- By 2021, the global consumer healthcare market will be worth over €180 billion.
- The market share of Haleon, the world leader in consumer healthcare, is estimated at 6% in 2021.
- The over-the-counter segment accounts for 90 billion euros, vitamins, minerals and supplements for 50 billion euros, and oral care for almost 30 billion euros.
- Its Dupixent sales approach 11 billion euros in annual sales.
- Beyfortus vaccine is currently marketed in 4 countries, including France.
Sanofi inaugurates Europe's largest vaccine plant at Val-de-Reuil 07/09/2023
- Sanofi's vaccine plant in Val-de-Reuil celebrated its 50th anniversary.
- Sanofi has invested 250 million euros in two modernization/expansion projects at the plant, which employs 2,200 people.
- It ships 600 million doses of vaccines worldwide every year.
- Sanofi has set up a new influenza vaccine production unit, at a cost of 200 million euros.
- Over the past ten years, Sanofi has invested 600 million euros in Val-de-Reuil.
- Sanofi plans to double sales of its vaccines division between 2018 and 2030, to more than 10 billion euros a year.
Sanofi invests $250 million in flu vaccines in France | Sanofi invests $250 million in flu vaccines in France 07/09/2023
- Sanofi is the world's fourth-largest vaccines company
- Sanofi invests 250 million euros in its Val-de-Reuil site, Europe's largest vaccine production facility
- Sanofi has 11 vaccine plants
- 50% of Sanofi's production is concentrated in influenza.
- Sanofi increases influenza vaccine production capacity by 40%
- Sanofi's Efluelda vaccine is recommended for the elderly and launched in 18 countries, including 11 where it has been recommended by health authorities.
- Sanofi has invested over 600 million euros in its Val-de-Reuil site over the past ten years.
Sanofi gains a foothold in the obesity market with biotech Adocia 10/07/2023
- Appetite suppressants derived from antidiabetics are an emerging market
- . Industry giants such as American Lilly and Danish Novo Nordisk are already involved in this market.
- Sanofi paid 10 million for the exclusive right to negotiate a worldwide partnership for Adocia's M1Pram rapid insulin.
- Adocia's M1Pram rapid insulin is special in that it makes you lose weight instead of gaining it.
- The potential market for appetite suppressants derived from antidiabetics is estimated at several tens of billions of dollars a year.
- Sanofi is a specialist in type 1 diabetes, and M1Pram could benefit obese patients suffering from this type of diabetes - around 5% of type 2 diabetics.
- Phase 2 clinical results for M1Pram showed exceptional weight loss with good glycemic control in overweight and obese type 1 diabetics.
- The population that could benefit from M1Pram is estimated at nearly 40 million people worldwide, representing a potential market worth several billion dollars.
Sanofi finally has its Covid-19 vaccine 13/11/2022
- Doses ready for distribution
- The French laboratory has accepted the dominance of the RNA vaccine and the American Moderna and German BioNTech
- The recombinant protein technology used in its VidPrevtyn Beta will make it possible to vaccinate populations in regions where the cold chain is difficult to maintain
Financial Data
DUNS: 403335904
Legal Name: SANOFI-AVENTIS FRANCE
Address: 82 AV RASPAIL , 94250 GENTILLY
Number of employees: Entre 2 000 et 4 999 salariés (2020)
Capital: 645 777 EUR
Financial Data:
| Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|
| Turnover | 1 580 000 000 | 1 743 000 000 | 1 795 000 000 | 1 981 000 000 | 2 123 000 000 | 1 837 000 000 | 1 937 000 000 |
| Gross margin (€) | 777 000 000 | 805 000 000 | 3 079 000 000 | 862 000 000 | 3 482 000 000 | 3 141 000 000 | - |
| EBITDA (€) | 201 000 000 | 207 000 000 | 104 000 000 | 88 000 000 | 127 000 000 | 3 867 000 000 | - |
| Operating profit (€) | 175 000 000 | 186 000 000 | 174 000 000 | 88 000 000 | 163 000 000 | 245 000 000 | - |
| Net profit (€) | 142 000 000 | 159 000 000 | -29 000 000 | 92 000 000 | 113 000 000 | 66 000 000 | 105 000 000 |
| Turnover growth rate (%) | -9,4 | -2,9 | -9,4 | -6,7 | 15,6 | -5,2 | - |
| Ebitda margin rate (%) | 12,7 | 11,9 | 5,8 | 4,4 | 6 | - | - |
| Operating margin rate (%) | 11,1 | 10,7 | 9,7 | 4,4 | 7,7 | - | - |
| Working Capital (turnover days) | 125,7 | 133 | 104,2 | -26,5 | -16,5 | - | - |
| Working Capital requirements (turnover days) | 16,4 | 38,3 | 33,8 | -7,2 | 2,9 | - | - |
| Net margin (%) | 9 | 9,1 | -1,6 | 4,6 | 5,3 | - | - |
| Added value / Turnover (%) | 29,6 | 29,7 | 174,2 | 22,6 | 176,9 | - | - |
| Wages and social charges (€) | 229 000 000 | 253 000 000 | -296 000 000 | 383 000 000 | -308 000 000 | -292 000 000 | - |
| Salaries / Turnover (%) | 14,5 | 14,5 | -16,5 | 19,3 | -14,5 | - | - |
Company Managers:
| Position | First Name | Last Name | Age | |
|---|---|---|---|---|
| Président du conseil d'administration, Directeur général, Administrateur | Audrey | DUVAL | 47 | |
| Directeur général délégué | Jean-Marc | LACROIX | 54 | |
| Directeur général délégué | Emmanuelle | FOUCHS | 57 |
Studies mentioning this company
The gene therapy market - France
Other companies mentioned:
- Sanofi Aventis
- Cellectis
- Généthon
- Gensight Biologics
The pharmacy market - France
Other companies mentioned:
- Giphar groupe
- Pharmactiv (OCP Group)
- Alphega Pharmacie
- Giropharm
- Leader Sante Groupe
- Tanguy Parapharmacie
- Arkopharma
- BERGLAND PHARMA GMBH & CO. KG
- Sanofi Aventis
- Novartis
- Hygie 31- Laf Santé Lafayette
- Elsie Santé
- Pharmacorp (Hygie 31 groupe)
- Leader Price
- Pharmabest
- Sephora
- Aprium Pharmacie - Healthy Group
- OCP Répartition (Phoenix Group)
- Phoenix Pharma
- Pharmony
- Apsara
- Pharma Santé Développement
- La cooperative Welcoop
- Global Pharmacie
- Aelia
- Cofisanté
- Eurodep
- Agir Pharma
- APM Les Pharmacies de Méditérannée
- Apothéo
- Apothical
- Apothicoop
- APP Côte d'azur
- Aptiphar
- Artesipharm
- Artisan Santé
- ASPIC
- Avenir Pharma
- Be Pharma
- Boticinal
- Bretagne Santé Référence
- Cali Pharma
- Cap unipharm
- Cercle des Pharmaciens Coopérateurs
- Coté Pharma
- Dephie
- DL santé
- DPGS
- DPO Groupe
- Dynamis
- Elfimaje Majelis
- Escale santé
- Evolupharm
- Farmax
- Flexi Plus Pharma
- Forum santé
- G Plus Pharma
- GFC Pharma
- Gripamel
- Groupapharm
- Happy Pharmacie
- Hello Pharmacie
- Lab Officine
- Le Gall santé Services
- Les Pharmaciens d'armor
- Magdaléon
- Maxipharma
- Mediprix
- Mutualpharm
- Nextypharm
- Normandie Pharma
- Norpharma
- Objectif Pharma
- OmnesPharma
- Optopharm
- Originsanté
- Orphie Groupement de Pharmaciens
- Orphie Provence
- Oté pharma
- Paraph
- PDA Pharma
- Pharm & Free
- Pharm Auvergne
- Pharm O Naturel
- Pharm Upp
- Pharm-Agir
- Pharma 10
- Pharma france
- Pharma Platinum
- Pharma provence Groupe
- Pharma Sud
- Pharma Synergie
- Pharmaciens du sud
- Pharmacies groupe Rocade
- Pharmacyal
- Pharmadinina
- Pharmadirect
- Pharmadn
- Pharm ici
- Pharmamarket (Antwerpia groupe)
- Pharmarem
- Pharmatomic
- Pharmavance
- Pharmavenir
- Pharmaxial
- Pharmidée
- Pharmodel
- Positive Pharma
- Quartz groupement Pharmacies
- Réseau Katalys
- Réseau P&P
- Réseau Pharma Méditerranée
- Réseau Santé
- Resofficine
- Resonor Soprophar
- Santalis
- Socopharm
- Sofiadis
- Solution Réseau d'Achat Pharm Etoile
- Sopharef
- STC Pharma
- Sunipharma
- Suprapharm
- Synaps Pharma
- Synergiphar
- Teleconsult Pharma
- Totum pharmaciens
- UDPGO
- Union des Grandes Pharmacies
- Unipharm
- Unipharm Loire Océan
- Univers Pharmacies
- VPharma
- Ynova group
The antidepressant market - Italy
Other companies mentioned:
- Pfizer
- CHIESI FARMACEUTICI SPA
- Sanofi Aventis
- Merck Serono S.p.a.
- Angelini Pharma
- Alfasigma S.p.a.
- Eli Illy S.p.a.
- MSD Italia S.p.a.
- A. Menarini Industrie Farmaceutiche Riunite S.r.l.
- ABBVIE S.r.l.
The Parapharmacy Market - France
Other companies mentioned:
- Parashop Diffusion
- Nocibé (Douglas Groupe)
- Weleda
- Pharmavie
- Giphar groupe
- Elsie Santé
- Lemoine Groupe
- Sanofi Aventis
- Pierre Fabre
- Eau Thermale d'Avène (Pierre Fabre Groupe)
- NAOS Bioderma
- Pharmazon
- Pharm Upp
- Objectif Pharma
- Mediprix
- Hygie 31- Laf Santé Lafayette
- Docmorris DoctiPharma
- Atida Santé Discount
- Paraland – BeautéLand
- Nepenthès
- Alliance Healthcare Repartition (Ahr)
- Alloga France
- Annah
- Asept Inmed
- Cerp De Bretagne Atlantique Cerp (Cooperative D'Exploitation Et De Repartition Pharmaceutique De Bre
- Cerp De Rouen (Cie D'Exploitation Et De Repartition Pharmaceutiques De Rouen)
- Cerp Rhin Rhone Mediterranee (Confraternelle D'Exploitation Et De Repartition Pharmaceutique Rhin Rh
- Continental Pharmaceutique
- Espace Santé D'Etrembières
- Espace Santé Lagoon Parapharmacie
- Eur Im Ex Pharma
- Eurapharma
- Gpg
- Intermed Exportation
- Ocp Repartition
- Para Nova
- Para Pont
- Para Stephie
- Paradis
- Paramad Gorin
- Paranicodis
- Parapharmacie Et Découverte
- Parasens
- Phoenix Pharma
- Solopara
- Sté Pharmaceutique Antillaise (Sopharma)
- Sté Pharmaceutique Guyanaise (Spg)
- Sté Reunionnaise De Distribution Pharmaceutique (Soredip)
- Tedis
- Ubipharm Guadeloupe
- Ubipharm Guyane (Cophaguy)
- Ubipharm Martinique
The pharmacy market - Spain
Other companies mentioned:
- Sanofi Aventis
- Novartis
- Hygie 31- Laf Santé Lafayette
- Johnson & Johnson
- Pfizer
- Roche Groupe
- Cofares S.c. Farmaceutica Española
- Grupo Bidafarma S.c. Andaluza De Segundo Grado
- Alliance Healthcare España Sociedad Anonima
- Hermandad Farmaceutica Del Mediterraneo S.c.l.
- Grupo Unnefar S.c.
- Janssen Cilag Sa
- Merck Sharp & Dohme De España Sau
- Almirall